Rating Change
Wells Fargo reiterated its Overweight rating on Biogen Inc. (NASDAQ:BIIB) on October 20, 2026.
reiterateNASDAQ:BIIB
Wells Fargo Reiterates Overweight Rating on Biogen Inc. (BIIB)
Wells Fargo reiterated its Overweight rating on Biogen Inc. (NASDAQ:BIIB) on October 20, 2026.
At publication ·
What changed
Biogen Inc. (NASDAQ:BIIB) · reiterate
- Firm
- Wells Fargo
- Rating
- Overweight to Overweight
- Price at event
- $242.28
- Market capitalization
- $25.3B
At a glance
Key takeaways
- Wells Fargo maintained an Overweight rating on Biogen (BIIB) on October 20, 2026, with the stock trading at $242.28 and a market cap of $25.3 billion.
Market Context
Biogen Inc. operates in the Healthcare sector. The stock currently trades at $242.28 with a market capitalization of $25.3B. The stock has gained 32.4% over the past 52 weeks.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Biogen Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Biogen Inc.
Among the 10 most recent ratings: 8 Buy, 1 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | Wells Fargo | Overweight | N/A |
| Oct 12, 2026 | JP Morgan | Overweight | N/A |
| Oct 09, 2026 | UBS | Buy | N/A |
| Oct 08, 2026 | RBC Capital | Outperform | N/A |
| Sep 10, 2026 | HSBC | Reduce | N/A |
Related Tools: Analyst Ratings Dashboard | View BIIB Stock Page
Frequently Asked Questions
What does the Overweight rating mean for BIIB?
A rating of Overweight from Wells Fargo reflects the analyst's outlook on Biogen Inc. (NASDAQ:BIIB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BIIB forecast page.
